# Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

> **NCT00983268** · PHASE1 · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Pancreatic Cancer
- Periampullary Adenocarcinoma

## Interventions

- **DRUG:** capecitabine
- **DRUG:** vorinostat
- **RADIATION:** Radiotherapy
- **PROCEDURE:** Surgery to remove tumor

## Key facts

- **NCT ID:** NCT00983268
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983268, "Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00983268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*